Reportlinker Adds Top 20 Cancer Therapy Brands in Australia Forecast

NEW YORK, April 1 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Top 20 Cancer Therapy Brands in Australia Forecast

http://www.reportlinker.com/p0185111/Top-20-Cancer-Therapy-Brands-in-Australia-Forecast.html

Introduction

The Top 20 cancer therapy brands in Australia reached sales of about $545m in 2008, growing at a CAGR of 30% since 2005. Datamonitor forecasts this growth to slow down considerably to a CAGR of 5.6% between 2008 and 2018 mainly due to maturing markets and the entry of generics for several key products. Sales of the Top 20 brands are expected to reach a total of $940m in 2018.

Reasons to Purchase

*Identify key opportunities and threats that will impact the Australian oncology market as a whole and the Top 20 in particular

*Quantify the future size and scope of the Top 20 Australian cancer therapies market and predict the performance of its key compounds

*Understand critical success factors in growing and defending cancer brand franchises from new entrants and generics

To order this report:

Therapy Industry: Top 20 Cancer Therapy Brands in Australia Forecast

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

SOURCE Reportlinker